Earlier in 14 December 2010, Meda took over three OTC consumer products from GSK.
Meda is an international specialty pharma company engaged in marketing and product development in late clinical phase.
Meda claims that its products are sold in 120 countries worldwide and the company is represented by its own organisations in 50 countries.
Meda CEO Anders Lonner said that by adding these two consumer brands, they continue to develop their US OTC presence.